(19)
(11) EP 3 638 244 A1

(12)

(43) Date of publication:
22.04.2020 Bulletin 2020/17

(21) Application number: 18735151.5

(22) Date of filing: 12.06.2018
(51) International Patent Classification (IPC): 
A61K 31/52(2006.01)
A61K 9/08(2006.01)
A61K 9/107(2006.01)
A61P 15/00(2006.01)
 A61K 9/06(2006.01)
A61K 9/10(2006.01)
A61K 31/715(2006.01)
(86) International application number:
PCT/US2018/036981
(87) International publication number:
WO 2018/231739 (20.12.2018 Gazette 2018/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 12.06.2017 US 201715620430

(71) Applicant: Harrow IP, LLC
San Diego, CA 92130 (US)

(72) Inventors:
  • BUDERER, Matthew J.
    Oak Harbor Ohio 43449 (US)
  • SAADEH, Dennis
    San Diego California 92130 (US)
  • BOLL, Andrew R.
    San Diego California 92130 (US)

(74) Representative: Høiberg P/S 
Adelgade 12
1304 Copenhagen K
1304 Copenhagen K (DK)

   


(54) PHARMACEUTICAL FORMULATIONS OF XANTHINE OR XANTHINE DERIVATIVES, AND THEIR USE